Enobia Pharma brings in $15mm of potential $47mm via Series D; round reaches $40mm
In what appears to be its fourth financing round, Enobia Pharma Inc. (developing drugs for genetic bone disorders for which there are no available treatments) raised $15mm from seven undisclosed investors. According to the Form D filing, the company could raise up to $47mm in three tranches. Enobia’s last fund-raise was an August 2009 Series C that generated $50mm; that money was expected to last through mid-2011.
- Venture Financing
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.